Skip to main content

Day: March 1, 2024

Monument Reports Second Quarter Fiscal 2024 (“Q2 FY2024”) Results

Revenue of US$11.00 Million and Cash Cost of US$894/Oz VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” today announced its second quarter of fiscal 2024 production and financial results for the three and six months ended December 31, 2023. All amounts are expressed in United States dollars (“US$”) unless otherwise indicated (refer to www.sedar.com for full financial results). President and CEO Cathy Zhai commented, “Q2 FY2024 was a strong quarter at the Selinsing Gold Mine with sulphide gold processing plant performance optimization and improvements resulting in greater feed rates and a more streamlined sales process. We are working hard on corporate development and development of the Murchison Gold Project and be prepared for the move.” Second...

Continue reading

Press release of the Ad-Hoc Committee of Believe following precision by the consortium on its proposed offer

Press release of the Ad-Hoc Committee of Believe following precision by the consortium on its proposed offer Paris, 1st March 2024 – On 12 February 2024, a consortium formed by the EQT X fund, funds advised by TCV, and Denis Ladegaillerie, acting through a dedicated entity (“BidCo”) has indicated to the Company that it would launch a tender offer (the “Offer”) on the shares of Believe (the “Company”) at a price per share of 15 euros, following the acquisition of blocks representing 71.92% of the share capital and 77.42% of the theoretical voting rights of the Company (the “Block Acquisitions”). The Blocks Acquisitions and the ensuing Offer were indicated to be subject to, on the one hand, obtaining the necessary regulatory approvals (the “Regulatory Condition”), and, on the other hand, on the Board of Directors of Believe giving its positive...

Continue reading

Vallourec Fourth Quarter and Full Year 2023 Results

Meudon (France), March 1st, 2024 Vallourec, a world leader in premium tubular solutions, announces today its results for the fourth quarter and full year 2023. The Board of Directors of Vallourec SA, meeting on February 29th 2024, approved the Group’s fourth quarter and full year 2023 Consolidated Financial Statements. Fourth Quarter and Full Year 2023 ResultsStrong full year 2023 EBITDA of €1,196m, above upper end of guidance range Sequential EBITDA improvement in Q4 due to strong execution International Tubes demand and pricing continue to increase US OCTG demand has stabilized, Vallourec shipments increasing Net debt halved YoY to €570m; expected to decline further in H1 and Full Year 2024 starting in Q1 2024aHIGHLIGHTS Strong Q4 and FY 2023 profitability and continued deleveraging:Q4 EBITDA of €280 million (up €58 million...

Continue reading

IMCD reports EBITA of EUR 515 million in 2023

Rotterdam, The Netherlands (1 March 2024) – IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its full year 2023 results. HIGHLIGHTSGross profit of EUR 1,123 million (+2% on a constant currency basis) Operating EBITA decline of 7% to EUR 515 million (-3% on a constant currency basis) Net result for the year decline of 7% to EUR 292 million (-3% on a constant currency basis) Free cash flow increase by 28% to EUR 554 million (2022: EUR 434 million)  Cash earnings per share decline of 6% to EUR 6.41 (2022: EUR 6.78) Dividend proposal of EUR 2.24 in cash per share (2022: EUR 2.37)Valerie Diele-Braun, CEO: “Following a year of exceptional growth, 2023 was a year characterised by challenging market conditions and reduced demand. Despite...

Continue reading

Aegon reports second half year 2023 results

Please click here to access all 2H 2023 results related documents. The Hague, March 1, 2024 – IFRS resultsNet result of EUR 0 million with operating result offset by realized losses on investment portfolio; net loss of EUR 199 million for the full-year Operating result of EUR 681 million, down 32% due to previously executed management actions and one-time benefits in the prior period. Full-year 2023 operating result of EUR 1,498 million, a decrease of 17% from EUR 1,802 million in 2022 Shareholders’ equity reduces by EUR 0.7 billion to EUR 7.5 billion following EUR 1.1 billion capital returns. Shareholders’ equity per share remains stable at EUR 4.27Capital generation, cash and capital managementOperating capital generation before holding funding and operating expenses increases by 16% compared with the second half of 2022...

Continue reading

Norsk Hydro: Pål Kildemo to leave Hydro

Pål Kildemo, Executive Vice President and CFO, has decided to leave Hydro to take the position as CFO in Emirates Global Aluminium (EGA). The process to find a new CFO in Hydro has started. Kildemo will continue in Hydro until August 31, 2024, at latest.Investor contact: Martine Rambøl Hagen +47 91708918 Martine.Rambol.Hagen@hydro.com Media contact: Anders Vindegg +47 93864271 Anders.Vindegg@hydro.com

Continue reading

Corbion: full year 2023 results

Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today publishes its results for the year ending 31 December 2023. Key highlights annual results 2023:Sales € 1,443.8 million; an organic increase of 1.2% Adjusted EBITDA € 191.8 million; an organic increase of 10.3% Operating profit € 117.2 million; an organic increase of 20.8% Organic growth core activities: Sales 3.0% & Adjusted EBITDA 16.2% Q4 2023:Sales € 352.8 million and Adjusted EBITDA € 49.0 million Organic growth core activities: Sales -0.5% & Adjusted EBITDA 29.3%Free Cash Flow full year € 18.6 million Covenant net debt/covenant EBITDA improved to 3.1x at year-end Proposed regular cash dividend of € 0.61 per share, an increase of 9% versus prior year reflecting the positive free cash flow...

Continue reading

IMCD announces dividend proposal and Supervisory Board nominations for reappointment

ROTTERDAM, The Netherlands (1 March 2024, 07:00 CET) – IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, formulator of speciality chemicals and ingredients, today announces its proposal to shareholders to adopt a dividend of EUR 2.24 per share in cash at the 2024 Annual General Meeting (‘AGM”), with the following dividend calendar:14 May 2024               AGM / Dividend announcement 16 May 2024               Ex-dividend date 17 May 2024               Dividend record date 21 May 2024               Dividend payment dateIn addition, IMCD’s Supervisory Board announces that it nominates Mr. Janus Smalbraak and Mrs. Amy Hebert for reappointment at the 2024 AGM, to continue in the Supervisory Board in their current roles. These nominations aim to secure consistency and continuity of the Supervisory...

Continue reading

Aegon proposes to re-elect CEO Lard Friese

The Hague, March 1, 2024 – Aegon announces today that its Board of Directors intends to nominate Lard Friese for re-election as Executive Director and CEO at the Annual General Meeting of Shareholders (AGM) on June 12, 2024, for a further four years. Mr. Friese began his tenure as the CEO of Aegon in 2020, after having worked in the insurance industry for over 30 years. William Connelly, Chairman of the Board of Directors (BoD), said: “We are very pleased to nominate Lard Friese for a further term as Executive Director and CEO. Under his leadership, Aegon has embarked on a transformation with the ambition to build leading businesses in investment, protection, and retirement solutions. During this period, Aegon has become a more focused company with improved operational performance, a stronger balance sheet, and an enhanced risk profile....

Continue reading

Tarsus Announces Pricing of $100.0 Million Public Offering

IRVINE, Calif., March 01, 2024 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the pricing of an underwritten public offering of 2,812,500 shares of its common stock at a public offering price of $32.00 per share, and, in lieu of common stock to a certain investor, pre-funded warrants to purchase up to 312,500 shares of its common stock at a public offering price of $31.9999, which represents the per share public offering price for the common stock less the $0.0001 per share exercise price for each pre-funded warrant. In addition, Tarsus has granted the underwriters a 30-day option to purchase up to an additional 468,750...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.